SCHEMBL8891485

SCHEMBL8891485

COc1ccc(Nc2nc(Nc3ccc(CCCO)cc3)nc3ccccc23)cc1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MERTK Q12866 5/20 0.73
NPY5R Q15761 3/20 0.72
SLC2A1 P11166 1/20 0.64
MEN1 O00255 3/20 0.57
KMT2A Q03164 3/20 0.57
MAPT P10636 2/20 0.57
MAPK1 P28482 2/20 0.57
NPC1 O15118 1/20 0.57
ALDH1A1 P00352 1/20 0.57
TP53 P04637 1/20 0.57
RAB9A P51151 1/20 0.57
SMN1; SMN2 Q16637 1/20 0.57
LMNA P02545 1/20 0.55
ABCG2 Q9UNQ0 1/20 0.55
RAD52 P43351 2/20 0.54
KDM4E B2RXH2 1/20 0.53
HTT P42858 1/20 0.53
TAAR1 Q96RJ0 1/20 0.53
HTR2A P28223 1/20 0.53
PIN1 Q13526 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL8900133 0.99 MERTK (0.72) MERTKNPY5RSLC2A1MEN1KMT2A
SCHEMBL8892609 0.91 KDM4E (0.67) MERTKNPY5RSLC2A1MEN1KMT2A
SCHEMBL8890638 0.90 NPY5R (0.67) MERTKNPY5RKMT2AMAPTALDH1A1
SCHEMBL8889582 0.87 NPY5R (0.76) MERTKNPY5RSLC2A1MEN1KMT2A
SCHEMBL2590796 0.86 NPY5R (0.97) MERTKNPY5RSLC2A1MEN1KMT2A
SCHEMBL16404310 0.85 NPY5R (0.73) MERTKNPY5RSLC2A1MEN1KMT2A
SCHEMBL8909187 0.85 NPY5R (1.00) MERTKNPY5RSLC2A1MEN1KMT2A
Hydrochloric Acid SCHEMBL8897702 0.85 NPY5R (0.94) MERTKNPY5RSLC2A1MEN1KMT2A
SCHEMBL8892796 0.84 NPY5R (0.76) MERTKNPY5RSLC2A1MEN1KMT2A
SCHEMBL8889361 0.84 KDM4E (0.70) MERTKNPY5RSLC2A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1997020822-A1 QUINAZOLIN-2,4-DIAZIRINES AS NPY RECEPTOR ANTAGONIST NOVARTIS AG (CH) 1997-06-12 WO claimed